Home
Our technology
Articles
More
Nature
Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1A
Elsevier
Supramolecular organization and biological interaction of squalenoyl siRNA nanoparticles
Journal of Clinical Toxicology
Optimizing Structure and Activity of the Squalenoyl-siRNA Nanoparticles
Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the present and the future
Small interfering RNA from the lab discovery to patients' recovery
CNRS
Charcot-Marie Tooth disease: A 100% French RNA-based therapeutic innovation
Académie nationale de Pharmacie
ARN interferant : un traitement innovant pour la maladie de Charcot-Marie-Tooth 1A
INSERM
Maladie de Charcot-Marie Tooth : une innovation thérapeutique 100 % française à base d’ARN
Téléthon
CMT 1 A : un nouvel ARN interférent prometteur
Youtube
Étude siRNA pour la CMT
Radio Canada
Charcot-Marie-Tooth : espoir de traitement
